Unlike many other mouse models, the AppNL-G-F line is capable of generating elevated levels of Aβ without overexpressing APP, which may provide an advantage for AD sleep research by reducing unintended interactions that may alter sleep in a way that differs from AD patients with endogenous APP levels (Maezono et al., 2020). This evidence concerns the gene APP and Alzheimer disease.